Skip to main content
Premium Trial:

Request an Annual Quote

Norwegian Firm Genetic Analysis Awarded $1.9M to Develop Microbiome Test for IBD Treatment

NEW YORK ─ The Norwegian Research Council has awarded NOK 16 million ($1.9 million) to Genetic Analysis for the development of a microbiome-based diagnostic test for the selection and treatment of patients with inflammatory bowel disease, the test developer said on Tuesday.

The Oslo, Norway-based molecular diagnostic company said it will use the funds to develop an easy-to-use test that profiles gut microbiota to predict disease progression and suggest treatment regimes for patients with ulcerative colitis. Its GA-map platform is based on a multiplex approach for the simultaneous analysis of a large number of bacteria in one reaction and uses a software algorithm to provide results without a need for further bioinformatics, the firm said.

Genetic Analysis CEO Ronny Hermansen said in a statement that the grant from the Norwegian Research Council will support the firm's work to improve treatment outcomes, lower treatment costs, and improve the quality of life for patients suffering from ulcerative colitis.

The firm said it will develop and validate the test in collaboration with R&D partners at Akershus University Hospital in Norway, and Sahlgrenska University Hospital and the University of Gothenburg in Sweden.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.